The India IVD Reagents Market was valued at $1026 Million in 2024 and projected to reach to $1688.2 Million by 2029, representing a compound annual growth rate of 10.5%. India's IVD reagents market is poised for accelerated growth through 2029, driven by increasing healthcare accessibility and rising disease prevalence across the nation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India's IVD reagents market is valued at USD 1,026.0 million in 2024 and is projected to grow to USD 1,688.2 million by 2029, representing a robust 10.5% CAGR, significantly outpacing the global growth rate of 7.7%.
Rapid expansion of diagnostic centers and laboratory infrastructure across urban and rural India is driving demand for IVD reagents, supported by government initiatives like Ayushman Bharat and increased private sector investments in healthcare.
Increasing prevalence of diabetes, cardiovascular diseases, and infectious diseases in India is fueling demand for diagnostic testing and IVD reagents, with growing awareness driving early detection and preventive healthcare practices.
Rising per capita healthcare spending and government budget allocations toward diagnostic infrastructure are creating favorable conditions for IVD reagent market expansion across India's diverse healthcare ecosystem.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 7.7% from 2024 to 2029 |
| Largest Segment | LABORATORY TESTS (Test Type) |
| Market Size Base Year (Billions) | ~USD 0.06 (2024) |
| Revenue Forecast (Billions) | ~USD 0.09 (2029) |
| Segments Covered | Type, Technology, Application, Test Type, End User |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC INSTITUTES | 80.4 | 85.2 | 90.6 | 97 | 104.6 | 113.6 | 124 | 136.1 | 8.5 |
| BLOOD BANKS | 71.3 | 76.1 | 81.5 | 88 | 95.6 | 104.5 | 115 | 127.1 | 9.3 |
| CLINICAL LABORATORIES | 630 | 683.5 | 743.5 | 815 | 899.3 | 998.7 | 1116.4 | 1253.7 | 11 |
| HOME CARE SETTINGS | 39.2 | 41.7 | 44.5 | 47.8 | 51.7 | 56.2 | 61.6 | 67.8 | 8.8 |
| HOSPITALS & CLINICS | 844.1 | 904 | 970.7 | 1050.1 | 1143.3 | 1252.7 | 1381.3 | 1529.9 | 9.5 |
| OTHER END USERS | 48.2 | 50.8 | 53.6 | 57 | 61 | 65.7 | 71.3 | 77.7 | 7.7 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 63.5 | 67.1 | 71.1 | 75.9 | 81.6 | 88.3 | 96.2 | 105.2 | 8.2 |
| TOTAL | 1776.7 | 1908.3 | 2055.5 | 2230.9 | 2437.1 | 2679.8 | 2965.9 | 3297.6 | 9.9 |
India's IVD reagents market was valued at USD 1,026.0 million in 2024 and is projected to reach USD 1,688.2 million by 2029.
India's IVD reagents market is expected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2029.
India's 10.5% CAGR significantly exceeds the global average of 7.7%, positioning India as a high-growth market within the Asia Pacific region.
Key drivers include rising healthcare expenditure, increasing chronic disease prevalence, expanding diagnostic infrastructure, government health initiatives, and growing awareness of preventive healthcare in India.
India's cost-effective manufacturing base, large patient population, and growing diagnostic capabilities make it a significant regional supplier and consumer of IVD reagents in Asia Pacific.
To determine the current size of the IVD reagents market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.
The four steps involved in estimating the market size are
Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (World Bank, World Health Organization, Centers for Disease Control and Prevention, and the US Food and Drug Administration); corporate filings (annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; and trade, business, and professional associations.
A thorough method was used in the primary research phase, which involved interviewing a wide range of sources from the supply and demand sides. The purpose of these interviews was to obtain the quantitative and qualitative information needed to put up this report. The main sources of information were industry experts from both core and related sectors, as well as preferred service provider, pioneers in technology, and organizations involved in every aspect of this industry's value chain. A variety of primary respondents, including important industry stakeholders, subject-matter experts, C-level executives from crucial market companies, and industry advisers, were carefully questioned in-depth. The goal was to gather and validate important qualitative and quantitative insights and to conduct a thorough assessment of future possibilities.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2024, Tier 1= >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION | |
|---|---|---|
| Enzene Biosciences Ltd. | Scientist | |
| Danaher Corporation | Director of Research & Development | |
| Thermo Fisher Scientific Inc. | Sales Manager | |
All major product providers offering various products and services were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value of the IVD reagents market was also split into various segments and subsegments at the region and country level based on:

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
In vitro diagnostic (IVD) reagents are chemicals or substances used to detect, measure, or produce a reaction with components of a sample in an IVD test. They are essential for accurately detecting biological markers or analytes in samples.
Full forecast, segment splits, and company analysis for all IVD Reagents Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report